Resveratrol: A potential challenger against gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 37, 2015, Pages 10636-10643

  Zulueta, Aida ^a   Caretti, Anna ^a   Signorelli, Paola ^a   Ghidoni, Riccardo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Cell cycle; Diet; Gastric cancer; Polyphenols; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; CAGA PROTEIN; CYCLIN D1; CYTOCHROME C OXIDASE; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; NUTRACEUTICAL; PIPERINE; PROTEIN KINASE C; PROTEIN P53; QUERCETIN; RESVERATROL; STAT3 PROTEIN; ANTIINFECTIVE AGENT; ANTIOXIDANT; POLYPHENOL; STILBENE DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BACTERICIDAL ACTIVITY; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; DIETARY INTAKE; DNA SYNTHESIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; FOOD INTAKE; G1 PHASE CELL CYCLE CHECKPOINT; HELICOBACTER PYLORI; HUMAN; INTRACELLULAR SIGNALING; MAXIMUM PLASMA CONCENTRATION; NEUTROPHIL; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; STOMACH CANCER; TUMOR GROWTH; WNT SIGNALING PATHWAY; ANIMAL; CANCER TRANSPLANTATION; CELL AGING; DIET; DISEASE COURSE; GENETIC EPIGENESIS; LIFESTYLE; MICROBIOLOGY; MOUSE; NUDE MOUSE; QUALITY OF LIFE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL AGING; CELL CYCLE; CELL PROLIFERATION; DIET; DISEASE PROGRESSION; EPIGENESIS, GENETIC; HELICOBACTER PYLORI; HUMANS; LIFE STYLE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYPHENOLS; QUALITY OF LIFE; SIGNAL TRANSDUCTION; STILBENES; STOMACH NEOPLASMS;

EID: 84942749286     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i37.10636     Document Type: Review

References (83)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009;125:666-673 [PMID: 19382179 DOI: 10.1002/ijc.24290]
3. Wu K, Nie Y, Guo C, Chen Y, Ding J, Fan D. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009;24:37-41 [PMID: 19196394 DOI: 10.1111/j.1440-1746.2008.05753.x]
4. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999;13 Suppl 1:3-11 [PMID: 10209681]
5. Ruggiero P. Helicobacter pylori infection: what's new. Curr Opin Infect Dis 2012;25:337-344 [PMID: 22555448 DOI: 10.1097/QCO.0b013e3283531f7c]
6. Chung MY, Lim TG, Lee KW. Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol 2013;19:984-993 [PMID: 23467658 DOI: 10.3748/wjg.v19.i7.984]
7. Yanaka A. Sulforaphane enhances protection and repair of gastric mucosa against oxidative stress in vitro, and demonstrates antiinflammatory effects on Helicobacter pylori-infected gastric mucosae in mice and human subjects. Curr Pharm Des 2011;17:1532-1540 [PMID: 21548875]
8. Langcake P, Pryce RJ. A new class of phytoalexins from grapevines. Experientia 1977;33:151-152 [PMID: 844529]
9. Dixon RA. Natural products and plant disease resistance. Nature 2001;411:843-847 [PMID: 11459067 DOI: 10.1038/35081178]
10. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005;16:449-466 [PMID: 16043028 DOI: 10.1016/j.jnutbio.2005.01.017]
11. Sanders TH, McMichael RW, Hendrix KW. Occurrence of resveratrol in edible peanuts. J Agric Food Chem 2000;48:1243-1246 [PMID: 10775379]
12. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 2004;52:4713-4719 [PMID: 15264904 DOI: 10.1021/jf040095e]
13. Matsuda H, Tomohiro N, Hiraba K, Harima S, Ko S, Matsuo K, Yoshikawa M, Kubo M. Study on anti-Oketsu activity of rhubarb II. Anti-allergic effects of stilbene components from Rhei undulati Rhizoma (dried rhizome of Rheum undulatum cultivated in Korea). Biol Pharm Bull 2001;24:264-267 [PMID: 11256482]
14. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220 [PMID: 8985016]
15. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012;3:141 [PMID: 22822401 DOI: 10.3389/fphar.2012.00141]
16. Frazzi R, Valli R, Tamagnini I, Casali B, Latruffe N, Merli F. Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Int J Cancer 2013;132:1013-1021 [PMID: 22833338 DOI: 10.1002/ijc.27748]
17. Ulrich S, Loitsch SM, Rau O, von Knethen A, Brüne B, Schubert-Zsilavecz M, Stein JM. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 2006;66:7348-7354 [PMID: 16849586 DOI: 10.1158/0008-5472. CAN-05-2777]
18. Björklund M, Roos J, Gogvadze V, Shoshan M. Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment. Cancer Chemother Pharmacol 2011;68:1459-1467 [PMID: 21479886 DOI: 10.1007/s00280-011-1640-x]
19. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000;78:429-441 [PMID: 10861841]
20. Wolter F, Akoglu B, Clausnitzer A, Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 2001;131:2197-2203 [PMID: 11481417]
21. Ding XZ, Adrian TE. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 2002;25:e71-e76 [PMID: 12409844]
22. Hsieh TC, Wu JM. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 1999;249:109-115 [PMID: 10328958 DOI: 10.1006/excr.1999.4471]
23. Kaneuchi M, Sasaki M, Tanaka Y, Yamamoto R, Sakuragi N, Dahiya R. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int J Oncol 2003;23:1167-1172 [PMID: 12964000]
24. Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 2002;63:99-104 [PMID: 11841782]
25. Daroch F, Hoeneisen M, González CL, Kawaguchi F, Salgado F, Solar H, García A. In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios 2001;104:79-85 [PMID: 11297014]
26. Mahady GB, Pendland SL. Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroenterol 2000;95:1849 [PMID: 10926010 DOI: 10.1111/j.1572-0241.2000.02146.x]
27. Mahady GB, Pendland SL, Chadwick LR. Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. Am J Gastroenterol 2003;98:1440-1441 [PMID: 12818294 DOI: 10.1111/j.1572-0241.2003.07513.x]
28. Holian O, Wahid S, Atten MJ, Attar BM. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physiol Gastrointest Liver Physiol 2002;282:G809-G816 [PMID: 11960777 DOI: 10.1152/ajpgi.00193.2001]
29. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 2011;11:211-218 [PMID: 21326325 DOI: 10.1038/nrc3017]
30. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3, 3'-digallate. FASEB J 2001;15:2022-2024 [PMID: 11511526 DOI: 10.1096/fj.01-0031fje]
31. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-1886 [PMID: 9414176]
32. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-7570 [PMID: 14633667]
33. Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol 2012;18:126-135 [PMID: 22253518 DOI: 10.3748/wjg.v18.i2.126]
34. Zaidi SF, Ahmed K, Yamamoto T, Kondo T, Usmanghani K, Kadowaki M, Sugiyama T. Effect of resveratrol on Helicobacter pylori-induced interleukin-8 secretion, reactive oxygen species generation and morphological changes in human gastric epithelial cells. Biol Pharm Bull 2009;32:1931-1935 [PMID: 19881312]
35. Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nasseri R, Thale J, Hahn EG, Konturek SJ. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001;33:222-229 [PMID: 11407666]
36. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002;295:683-686 [PMID: 11743164 DOI: 10.1126/science.1067147]
37. Martini S, Bonechi C, Rossi C, Figura N. Increased susceptibility to resveratrol of Helicobacter pylori strains isolated from patients with gastric carcinoma. J Nat Prod 2011;74:2257-2260 [PMID: 21936484 DOI: 10.1021/np100761u]
38. Shih A, Davis FB, Lin HY, Davis PJ. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 2002;87:1223-1232 [PMID: 11889192 DOI: 10.1210/jcem.87.3.8345]
39. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002;8:893-903 [PMID: 11895924]
40. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24:2783-2840 [PMID: 15517885]
41. Atten MJ, Attar BM, Milson T, Holian O. Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochem Pharmacol 2001;62:1423-1432 [PMID: 11709203]
42. Atten MJ, Godoy-Romero E, Attar BM, Milson T, Zopel M, Holian O. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs 2005;23:111-119 [PMID: 15744586 DOI: 10.1007/s10637-005-5855-8]
43. Caponigro F, French RC, Kaye SB. Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 1997;8:26-33 [PMID: 9147607]
44. Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O. Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World J Gastroenterol 2006;12:5628-5634 [PMID: 17007014]
45. Wang Z, Li W, Meng X, Jia B. Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1. Clin Exp Pharmacol Physiol 2012;39:227-232 [PMID: 22211760 DOI: 10.1111/j.1440-1681.2011.05660.x]
46. Shin KO, Park NY, Seo CH, Hong SP, Oh KW, Hong JT, Han SK, Lee YM. Inhibition of sphingolipid metabolism enhances resveratrol chemotherapy in human gastric cancer cells. Biomol Ther (Seoul) 2012;20:470-476 [PMID: 24009836 DOI: 10.4062/biomolther.2012.20.5.470]
47. Yang Q, Wang B, Zang W, Wang X, Liu Z, Li W, Jia J. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 2013;8:e70627 [PMID: 24278101 DOI: 10.1371/journal.pone.0070627]
48. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007;7:41-51 [PMID: 17186030 DOI: 10.1038/nri1995]
49. Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb) 2011;21:264-275 [PMID: 22420240]
50. Lu J, Zhang L, Chen X, Lu Q, Yang Y, Liu J, Ma X. SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth. Int J Clin Exp Med 2014;7:5050-5058 [PMID: 25664004]
51. Aquilano K, Baldelli S, Rotilio G, Ciriolo MR. trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun. signalling axis. Biochem Pharmacol 2009;77:337-347 [PMID: 19038233 DOI: 10.1016/j.bcp. 2008.10.034]
52. Signorelli P, Munoz-Olaya JM, Gagliostro V, Casas J, Ghidoni R, Fabrias G. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett 2009;282:238-243 [PMID: 19394759 DOI: 10.1016/j.canlet.2009.03.020]
53. Sala G, Minutolo F, Macchia M, Sacchi N, Ghidoni R. Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs Exp Clin Res 2003;29:263-269 [PMID: 15134383]
54. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 2003;17:2339-2341 [PMID: 14563682 DOI: 10.1096/fj.03-0292fje]
55. Cakir Z, Saydam G, Sahin F, Baran Y. The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells. J Cancer Res Clin Oncol 2011;137:279-286 [PMID: 20401667 DOI: 10.1007/s00432-010-0884-x]
56. Kartal M, Saydam G, Sahin F, Baran Y. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. Nutr Cancer 2011;63:637-644 [PMID: 21500096 DOI: 10.1080/01635581.2011.538485]
57. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005;11:280-284 [PMID: 15633232]
58. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506 [PMID: 16732220 DOI: 10.1038/nrd2060]
59. Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med 2004;36:829-837 [PMID: 15019968 DOI: 10.1016/j.freeradbi omed.2004.01.002]
60. Wenzel E, Somoza V. Metabolism and bioavailability of transresveratrol. Mol Nutr Food Res 2005;49:472-481 [PMID: 15779070 DOI: 10.1002/mnfr.200500010]
61. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R. Bioavailability of transresveratrol from red wine in humans. Mol Nutr Food Res 2005;49:495-504 [PMID: 15830336 DOI: 10.1002/mnfr.200500002]
62. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32:1377-1382 [PMID: 15333514 DOI: 10.1124/dmd.104.000885]
63. de Santi C, Pietrabissa A, Mosca F, Pacifici GM. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 2000;30:1047-1054 [PMID: 11197066 DOI: 10.1080/00498250010002487]
64. De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 2000;30:609-617 [PMID: 10923862 DOI: 10.1080/004982500406435]
65. Goldberg DM, Yan J, Soleas GJ. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003;36:79-87 [PMID: 12554065]
66. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011;1215:9-15 [PMID: 21261636 DOI: 10.1111/j.1749-6632.2010.05842.x]
67. Smoliga JM, Blanchard O. Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? Molecules 2014;19:17154-17172 [PMID: 25347459 DOI: 10.3390/molecules191117154]
68. Huang W, Chen Z, Wang Q, Lin M, Wu S, Yan Q, Wu F, Yu X, Xie X, Li G, Xu Y, Pan J. Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab Brain Dis 2013;28:585-595 [PMID: 23943324 DOI: 10.1007/s11011-013-9426-y]
69. De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 2000;30:857-866 [PMID: 11055264 DOI: 10.1080/004982500433282]
70. Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011;55:1169-1176 [PMID: 21714124 DOI: 10.1002/mnfr.201100117]
71. Pacifici GM. Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature. Int J Clin Pharmacol Ther 2004;42:488-495 [PMID: 15487807]
72. Tak JK, Lee JH, Park JW. Resveratrol and piperine enhance radiosensitivity of tumor cells. BMB Rep 2012;45:242-246 [PMID: 22531135]
73. Wightman EL, Reay JL, Haskell CF, Williamson G, Dew TP, Kennedy DO. Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br J Nutr 2014;112:203-213 [PMID: 24804871 DOI: 10.1017/S0007114514000737]
74. Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 2011;4:1419-1425 [PMID: 21680702 DOI: 10.1158/1940-6207. CAPR-11-0148]
75. Liang L, Liu X, Wang Q, Cheng S, Zhang S, Zhang M. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3, 5, 4'-tri-O-acetylresveratrol in rats. Phytomedicine 2013;20:558-563 [PMID: 23351959 DOI: 10.1016/j.phymed.2012.12.012]
76. Koide K, Osman S, Garner AL, Song F, Dixon T, Greenberger JS, Epperly MW. The Use of 3, 5, 4'-Tri-O-acetylresveratrol as a Potential Pro-drug for Resveratrol Protects Mice from γ-Irradiation-Induced Death. ACS Med Chem Lett 2011;2:270-274 [PMID: 21826253 DOI: 10.1021/ml100159p]
77. Mattarei A, Carraro M, Azzolini M, Paradisi C, Zoratti M, Biasutto L. New water-soluble carbamate ester derivatives of resveratrol. Molecules 2014;19:15900-15917 [PMID: 25275336 DOI: 10.3390/molecules191015900]
78. Chillemi R, Cardullo N, Greco V, Malfa G, Tomasello B, Sciuto S. Synthesis of amphiphilic resveratrol lipoconjugates and evaluation of their anticancer activity towards neuroblastoma SH-SY5Y cell line. Eur J Med Chem 2015;96:467-481 [PMID: 25932501 DOI: 10.1016/j.ejmech.2015.04.038]
79. Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011;12:279-286 [PMID: 21240574 DOI: 10.1208/s12249-011-9584-3]
80. Sessa M, Tsao R, Liu R, Ferrari G, Donsi F. Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion. J Agric Food Chem 2011;59:12352-12360 [PMID: 22026647 DOI: 10.1021/jf2031346]
81. Frozza RL, Bernardi A, Paese K, Hoppe JB, da Silva T, Battastini AM, Pohlmann AR, Guterres SS, Salbego C. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J Biomed Nanotechnol 2010;6:694-703 [PMID: 21361135]
82. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010;70:7392-7399 [PMID: 20841478 DOI: 10.1158/0008-5472. CAN-10-2027]
83. Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, Holcombe RF. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 2009;1:25-37 [PMID: 21188121]